Compare RGC & BILL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGC | BILL |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.2B |
| IPO Year | 2020 | 2019 |
| Metric | RGC | BILL |
|---|---|---|
| Price | $7.05 | $49.13 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 21 |
| Target Price | N/A | ★ $57.90 |
| AVG Volume (30 Days) | 149.4K | ★ 2.2M |
| Earning Date | 10-31-2025 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,653,160,000.00 |
| Revenue This Year | N/A | $14.18 |
| Revenue Next Year | N/A | $13.83 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 13.03 |
| 52 Week Low | $4.51 | $31.41 |
| 52 Week High | $69.00 | $57.21 |
| Indicator | RGC | BILL |
|---|---|---|
| Relative Strength Index (RSI) | 60.05 | 60.84 |
| Support Level | $4.71 | $50.26 |
| Resistance Level | $6.75 | $52.48 |
| Average True Range (ATR) | 0.45 | 1.85 |
| MACD | 0.25 | -0.16 |
| Stochastic Oscillator | 85.56 | 97.23 |
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
BILL Holdings Inc is a provider of software-as-a-service, cloud-based payments and spend and expense management products, which allow users to automate accounts payable and accounts receivable transactions, enable businesses to easily connect with their suppliers or customers to do business, eliminate expense reports, manage cash flows and improve back office efficiency. Initial Public Offering and Follow-on Offering.